Drugs / CKD-495
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial · 1 met primary | ||||||
| Phase 2 | NCT03437785 | Jan → Oct 2018 | gastritis | Chong Kun Dang Pharmaceutical | Completed | Met primary |
| Phase 31 trial · 1 met primary | ||||||
| Phase 3 | NCT04255589 | Jan 2020 → May 2021 | gastritis | Chong Kun Dang Pharmaceutical | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CKD-495 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04255589 ↗ |